| |
| |
NEW ON THE MARKET
|
| |
Agomelatine (VALDOXAN) for major depressive disorder
Low dose orlistat (ALLI) now OTC
|
| |
| |
THERAPY FROM A CRITICAL VIEWPOINT
|
| |
Clopidogrel and aspirin in patients with atrial fibrillation
Valsartan (DIOVAN): no protection against atrial fibrillation
Strict control of blood glucose in critical ill patients?
|
| |
| |
a-t READER'S QUESTIONS AND COMMENTS
|
| |
For how long adjuvant tamoxifen (e.g. NOLVADEX) in breast cancer
|
| |
| |
IN BRIEF
|
| |
Pharmaceutical quality of all tested gabapentin products okay
Calcium dobesilate without benefit in diabetic retinopathy
Merck & Co: dubious marketing strategies
|
| |
| |
CURRENT ADR NETWORK REPORT
|
| |
Are disposal boxes for syringes sufficient safe?
Erratum: non vertebral fractures due to ibandronate (e.g. BONVIVA)
|
| |
| |
SIDE EFFECTS
|
| |
 |
Sertindole (SERDOLECT): Cardiotoxicity confirmed
Strontium ranelate (PROTELOS) causes alopecia
Gastrointestinal perforation due to erlotinib (TARCEVA)
|
| |